Dr. Agarwal's Health Care Limited (BOM:544350)

Market Cap	144.99B +3.7%
Revenue (ttm)	19.76B +23.5%
Net Income	1.26B +40.6%
EPS	3.96 +28.5%
Shares Out	n/a
PE Ratio	115.03
Forward PE	85.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,405
Average Volume	9,320
Open	451.00
Previous Close	450.20
Day's Range	450.00 - 460.65
52-Week Range	327.40 - 567.80
Beta	n/a
RSI	63.66
Earnings Date	May 26, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Health Services
• Founded: 2010
• Employees: 4,214
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544350

Financial Performance

In fiscal year 2025, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.